siRNA: an alternative treatment for diabetes and associated conditions

Journal of Drug Targeting
Pravin Shende, Chirag Patel

Abstract

Diabetes is a condition that is not completely treatable but life of a diabetic patient can be smoothed by preventing or delaying the associate conditions like diabetic retinopathy, nephropathy, impaired wound healing process, etc. Apart from conventional methods to regulate diabetic condition, new techniques using siRNA have been emerged to prevent the associated conditions. This paper focuses on how siRNA used as a tool to silence the expression of genes which plays critical role in pathogenesis of these conditions. A marked improvement in wound-healing process of diabetic patients has been observed with siRNA treatment by silencing of Keap1 gene. Glucagon plays critical role in glucose homoeostasis and increases blood glucose level during hypoglycaemia. Glucose homoeostasis is impaired in diabetic patient and suppressing the expression of glucagon secretion with siRNA is used to suppress the progress of diabetes. Similarly, silencing expression of several factors has demonstrated improvement of treatment of diabetic nephropathy, retinopathy and inflammation by the use of siRNA.

References

Oct 30, 1992·Biochimica Et Biophysica Acta·S Yamamoto
Jul 2, 1992·Nature·D P Lane
Oct 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M N HelderS Vukicevic
Feb 2, 1996·The Journal of Biological Chemistry·A P LevyM A Goldberg
Aug 23, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·X Z Shu, K J Zhu
Mar 26, 2003·Journal of Molecular Biology·Dag R SørensenMouldy Sioud
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Oct 22, 2003·Cell·Anastasia KhvorovaSumedha D Jayasena
Dec 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Neema AgrawalSunil K Mukherjee
Feb 6, 2004·Nature Biotechnology·Angela ReynoldsAnastasia Khvorova
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick N CunninghamRichard J Quigg
Jun 23, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Maytal Bivas-BenitaGerrit Borchard
Jul 9, 2004·The Annals of Pharmacotherapy·Kimberley KrapekTeresa J Lubowski
Nov 25, 2004·Journal of Molecular Biology·Jung C Lee, Robin R Gutell
Jun 16, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vincent DolanHugh R Brady
Jun 28, 2005·Experimental Eye Research·Toshiyuki OshitariSayon Roy
Nov 26, 2005·Science·Kyle Kai-How FarhDavid P Bartel
Mar 1, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshinori KakizawaKazunori Kataoka
Apr 24, 2007·Advanced Drug Delivery Reviews·Lars Aagaard, John J Rossi
Jul 25, 2007·Journal of Cell Science·Haojie Huang, Donald J Tindall
Aug 25, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shubiao ZhangBaichao Ma
Feb 9, 2008·Cell Death and Differentiation·G-H Fong, K Takeda
Oct 23, 2008·International Journal of Pharmaceutics·Yogesh Patil, Jayanth Panyam
Aug 27, 2009·American Journal of Physiology. Endocrinology and Metabolism·Maziyar SaberiJerrold M Olefsky
Dec 17, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji Hoon JeongSung Wan Kim
Jul 9, 2010·American Journal of Ophthalmology·Peter K KaiserUNKNOWN Sirna-027 Study Investigators
Nov 17, 2010·The FEBS Journal·S Patrick WaltonChristina Chan
Mar 3, 2011·Archives of Toxicology·Liam Baird, Albena T Dinkova-Kostova
Oct 25, 2011·Journal of the American Society of Nephrology : JASN·Miao LinSydney C W Tang
Mar 29, 2012·Experimental Diabetes Research·Bhaskar PonugotiDana T Graves
Feb 9, 2013·Advances in Experimental Medicine and Biology·Kirti KaulRakesh Chibber
Aug 24, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Héloïse RagelleVéronique Préat
Dec 12, 2013·The Journal of Investigative Dermatology·Xiao-Qi WangAmy S Paller

❮ Previous
Next ❯

Citations

Mar 5, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Pravin Shende, Mansi Waghchaure
Jan 18, 2021·Stem Cell Reviews and Reports·Pravin Shende, Riddhi Trivedi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.